文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

小檗碱通过抑制炎症反应和细胞凋亡对多囊卵巢综合征大鼠发挥保护作用。

Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.

机构信息

Department of Gynecology, Obstetrics & Gynecology Hospital of Fudan University, No. 419 Fangxie Road, Shanghai, 200011, P.R. China.

Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, No. 419 Fangxie Road, Shanghai, 200011, P.R. China.

出版信息

Reprod Biol Endocrinol. 2021 Jan 7;19(1):3. doi: 10.1186/s12958-020-00684-y.


DOI:10.1186/s12958-020-00684-y
PMID:33407557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7789273/
Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disease of the female reproductive system that seriously affects women's health. Berberine (BBR) has many pharmacological properties and is used as an insulin sensitizer. This study aimed to investigate the effect of BBR on PCOS and explore its related mechanisms. METHODS: Forty-two rats were randomly divided into the following six groups (n = 7 per group): control, control + BBR, PCOS-normal diet (ND), PCOS-ND + BBR, PCOS-high-fat diet (HFD), and PCOS-HFD + BBR. The PCOS rat models were established by injecting rats with dehydroepiandrosterone. Further, the rats were gavaged with BBR (150 mg/kg/d) for 6 weeks. Then, the body weight, HOMA-IR, and testosterone levels of all rats were determined. Cell apoptosis of ovary granulosa cells was determined by a TUNEL assay kit. Real-time quantification PCR (RT-qPCR) and western blotting were utilized to evaluate the expression of TLR4, LYN, PI3K, Akt, NF-kB, TNF-α, IL-1, IL-6, and caspase-3. RESULTS: BBR reduced the levels of insulin resistance and testosterone in PCOS rats. Additionally, the cell apoptosis rate increased significantly in PCOS rats (P < 0.05) and decreased after BBR treatment (P < 0.05). The results of RT-qPCR and western blotting showed that the expression levels of TLR4, LYN, PI3K, Akt, NF-kB, TNF-α, IL-1, IL-6, and caspase-3 significantly increased in PCOS rats, while BBR suppressed their expression levels. CONCLUSIONS: BBR may relieve PCOS pathology and IR values by inhibiting cell apoptosis and by regulating the expression levels of TLR4, LYN, PI3K, Akt, NF-kB, TNF-α, IL-1, IL-6, and caspase-3.

摘要

背景:多囊卵巢综合征(PCOS)是一种常见的女性生殖系统内分泌疾病,严重影响妇女的健康。小檗碱(BBR)具有多种药理作用,可用作胰岛素增敏剂。本研究旨在探讨 BBR 对 PCOS 的影响,并探讨其相关机制。

方法:42 只大鼠随机分为以下六组(每组 n = 7):对照组、对照组+BBR、PCOS-正常饮食(ND)、PCOS-ND+BBR、PCOS-高脂肪饮食(HFD)和 PCOS-HFD+BBR。通过注射脱氢表雄酮建立 PCOS 大鼠模型。进一步,大鼠用 BBR(150 mg/kg/d)灌胃 6 周。然后测定所有大鼠的体重、HOMA-IR 和睾酮水平。用 TUNEL 试剂盒测定卵巢颗粒细胞的细胞凋亡。用实时定量 PCR(RT-qPCR)和蛋白质印迹法评估 TLR4、LYN、PI3K、Akt、NF-kB、TNF-α、IL-1、IL-6 和 caspase-3 的表达。

结果:BBR 降低了 PCOS 大鼠的胰岛素抵抗和睾酮水平。此外,PCOS 大鼠的细胞凋亡率显著增加(P < 0.05),BBR 治疗后降低(P < 0.05)。RT-qPCR 和蛋白质印迹法的结果表明,TLR4、LYN、PI3K、Akt、NF-kB、TNF-α、IL-1、IL-6 和 caspase-3 的表达水平在 PCOS 大鼠中显著升高,而 BBR 抑制了它们的表达水平。

结论:BBR 可能通过抑制细胞凋亡和调节 TLR4、LYN、PI3K、Akt、NF-kB、TNF-α、IL-1、IL-6 和 caspase-3 的表达水平来缓解 PCOS 病理和 IR 值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/3eafd5393ef5/12958_2020_684_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/281a139e7b91/12958_2020_684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/0b9e7f1a7a17/12958_2020_684_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/a88500811ee6/12958_2020_684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/57752a0c82eb/12958_2020_684_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/5fbc70307b93/12958_2020_684_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/3eafd5393ef5/12958_2020_684_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/281a139e7b91/12958_2020_684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/0b9e7f1a7a17/12958_2020_684_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/a88500811ee6/12958_2020_684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/57752a0c82eb/12958_2020_684_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/5fbc70307b93/12958_2020_684_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b3/7789273/3eafd5393ef5/12958_2020_684_Fig6_HTML.jpg

相似文献

[1]
Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.

Reprod Biol Endocrinol. 2021-1-7

[2]
Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.

J Ethnopharmacol. 2024-9-15

[3]
Ghrelin Alleviates Inflammation, Insulin Resistance, and Reproductive Abnormalities in Mice with Polycystic Ovary Syndrome via the TLR4-NF-κB Signaling Pathway.

Discov Med. 2024-5

[4]
Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression.

Phytomedicine. 2024-6

[5]
Effect of berberine combined with metformin on autophagy in polycystic ovary syndrome by regulating AMPK/AKT/mTOR pathway.

Mol Reprod Dev. 2024-8

[6]
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.

J Ethnopharmacol. 2019-6-8

[7]
The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.

Reprod Biol. 2023-6

[8]
Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.

Regul Toxicol Pharmacol. 2019-11-26

[9]
Berberine Protects Against Dihydrotestosterone-Induced Human Ovarian Granulosa Cell Injury and Ferroptosis by Regulating the Circ_0097636/MiR-186-5p/SIRT3 Pathway.

Appl Biochem Biotechnol. 2024-8

[10]
Chinese medicine compound prescription HeQi San ameliorates chronic inflammatory states and modulates gut flora in dehydroepiandrosterone-induced polycystic ovary syndrome mouse model.

Int Immunopharmacol. 2024-8-20

引用本文的文献

[1]
Pharmacological properties and therapeutic potential of berberine: a comprehensive review.

Front Pharmacol. 2025-8-14

[2]
The role of lncRNA HUPCOS in androgen metabolism and follicle growth arrest in polycystic ovary syndrome.

Cell Biol Toxicol. 2025-6-17

[3]
Berberine as a multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence.

Eur J Med Res. 2025-6-12

[4]
Obesity: pathophysiology and therapeutic interventions.

Mol Biomed. 2025-4-25

[5]
Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential.

Front Nutr. 2025-2-11

[6]
Dihydroberberine alleviates Th17/Treg imbalance in premature ovarian insufficiency mice via inhibiting Rheb/mTOR signaling.

Mol Med. 2024-10-29

[7]
Impact of high-fat diet on ovarian epigenetics: Insights from altered intestinal butyric acid levels.

Heliyon. 2024-6-15

[8]
Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs.

Front Endocrinol (Lausanne). 2023

[9]
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome.

Mol Med Rep. 2024-6

[10]
Liraglutide Improves PCOS Symptoms in Rats by Targeting FDX1.

Reprod Sci. 2024-7

本文引用的文献

[1]
Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome.

Curr Dev Nutr. 2019-10-3

[2]
Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.

Life Sci. 2019-10-8

[3]
Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment.

Int J Endocrinol Metab. 2019-7-27

[4]
Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.

Hum Reprod. 2019-8-1

[5]
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.

J Ethnopharmacol. 2019-6-8

[6]
Hypertension in Polycystic Ovary Syndrome: Novel Insights.

Curr Hypertens Rev. 2020

[7]
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.

Diabetes Care. 2019-1-31

[8]
The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.

Med Sci Monit. 2019-1-13

[9]
LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis.

Mol Med Rep. 2018-12-24

[10]
The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review.

Evid Based Complement Alternat Med. 2018-11-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索